Detalhe da pesquisa
1.
Conventional versus hypofractionated postmastectomy proton radiotherapy in the USA (MC1631): a randomised phase 2 trial.
Lancet Oncol
; 24(10): 1083-1093, 2023 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-37696281
2.
Patient-reported Adverse Events During Neoadjuvant Therapy in a Phase 2 Borderline Resectable Pancreatic Cancer Clinical Trial (Alliance A021501).
Ann Surg
; 278(4): 598-608, 2023 10 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37334719
3.
Phase II Trial of Trifluridine/Tipiracil Plus Irinotecan in Patients with Advanced, Refractory Biliary Tract Carcinoma.
Oncologist
; 28(10): 917-e966, 2023 10 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-37339254
4.
Ibrutinib Regimens versus Chemoimmunotherapy in Older Patients with Untreated CLL.
N Engl J Med
; 379(26): 2517-2528, 2018 12 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-30501481
5.
How much time do we have? Longitudinal perception of prognosis in newly-diagnosed high grade glioma patients and caregivers compared to clinicians.
J Neurooncol
; 152(2): 313-323, 2021 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-33486637
6.
Phase II Trial of Trifluridine/Tipiracil in Patients with Advanced, Refractory Biliary Tract Carcinoma.
Oncologist
; 25(5): 380-e763, 2020 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-31826977
7.
A Case Management System for Integrating Patient-reported Outcome Assessment in Clinical Practice: The Beacon Tool.
Med Care
; 57 Suppl 5 Suppl 1: S73-S79, 2019 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-30985599
8.
Dinaciclib, a novel CDK inhibitor, demonstrates encouraging single-agent activity in patients with relapsed multiple myeloma.
Blood
; 125(3): 443-8, 2015 Jan 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-25395429
9.
A pilot study of minocycline for the prevention of paclitaxel-associated neuropathy: ACCRU study RU221408I.
Support Care Cancer
; 25(11): 3407-3416, 2017 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-28551844
10.
Effect of First-Line Chemotherapy Combined With Cetuximab or Bevacizumab on Overall Survival in Patients With KRAS Wild-Type Advanced or Metastatic Colorectal Cancer: A Randomized Clinical Trial.
JAMA
; 317(23): 2392-2401, 2017 06 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-28632865
11.
A phase II study of bevacizumab and temsirolimus in advanced extra-pancreatic neuroendocrine tumors.
Endocr Relat Cancer
; 30(11)2023 11 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37702588
12.
A prospective, randomized trial of patient-reported outcome measures to drive management decisions in hematology and oncology.
Contemp Clin Trials Commun
; 29: 100964, 2022 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-35928285
13.
Pembrolizumab in Combination with Neoadjuvant Chemoradiotherapy for Patients with Resectable Adenocarcinoma of the Gastroesophageal Junction.
Clin Cancer Res
; 28(14): 3021-3031, 2022 07 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-35552651
14.
Randomized Phase II Study of PET Response-Adapted Combined Modality Therapy for Esophageal Cancer: Mature Results of the CALGB 80803 (Alliance) Trial.
J Clin Oncol
; 39(25): 2803-2815, 2021 09 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34077237
15.
Safety and activity of temsirolimus and bevacizumab in patients with advanced renal cell carcinoma previously treated with tyrosine kinase inhibitors: a phase 2 consortium study.
Cancer Chemother Pharmacol
; 75(3): 485-93, 2015 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-25556030